The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; none of the 36 sources its claims cite is checked for support yet.
Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder
Open accessAbstract
In this study, we used new technology to investigate whether a coherent pattern of enhanced expression of inflammatory and other immune activation genes in circulating monocytes is found in patients with major depression. Since a high inflammatory state of monocytes might be related to glucocorticoid resistance, we also included the genes for the two isoforms of the glucocorticoid receptor. For this study, we aimed at finding a similar coherent pattern of inflammatory and immune activation genes in monocytes of patients with MDD and recruited 47 medication-free melancholic MDD inpatients and 42 healthy controls. A quantitative-polymerase chain reaction (Q-PCR) monocyte gene expression analysis was performed using a panel of inflammatory-related genes previously identified as abnormally regulated in mood disorder patients. Selected serum cytokines/chemokines were assessed using a cytometric bead array. Depressive symptoms were analysed using Hamilton depression scores (HAMD). Thirty-four of the 47 monocyte inflammatory-related genes were significantly upregulated and 2 were significantly downregulated as compared to controls, the latter including the gene for the active GRα in particular in those with a high HAMD score. The reduced GRα expression correlated strongly to the upregulation of the inflammatory genes in monocytes. Serum levels of IL6, IL8, CCL2 and VEGF were significantly increased in patients compared to controls. Our data show the deregulation of two interrelated homoeostatic systems, that is, the immune system and the glucocorticoid system, co-occurring in major depression.
Overview
CoChat Summary
TL;DR
In medication-free melancholic major depressive disorder inpatients, circulating monocytes showed broad inflammatory gene upregulation and reduced active glucocorticoid receptor α (GRα) expression, with elevated serum IL6, IL8, CCL2, and VEGF. The reduced GRα/GRβ ratio correlated with inflammatory gene expression and depression severity, suggesting inflammation-associated glucocorticoid resistance.
Key findings
- In MDD patients versus controls, 34 of 47 monocyte inflammatory-related genes were significantly upregulated and 2 were significantly downregulated after Simes correction; upregulated genes were mainly in cluster 1 (26/29, 90%) and cluster 2 (8/14, 57%).
- Active GRα was significantly downregulated in MDD patients (F(1,86)=11.99, P=0.001), while inactive GRβ showed a non-significant trend toward upregulation; GRα downregulation negatively correlated with overexpression of cluster 1 (26/30) and cluster 2 (8/13) genes, and GRβ overexpression positively correlated with 27/30 cluster 1 and 8/13 cluster 2 genes.
- Serum IL6 (P=0.04), IL8 (P=0.004), CCL2 (P=0.04), and VEGF (P=0.028) were significantly increased in MDD patients versus controls; IL1β was not significant after Simes correction.
- The monocyte GRα/β ratio correlated with HAMD score after adjustment for age, gender, and BMI; serum IL8 negatively correlated with GRα/β (S=−0.389, P=0.008).
Methods
- Case-control study of 47 medication-free melancholic MDD inpatients (DSM-IV-TR/SCID-1; mean HAMD17 24.4, range 18–30) and 42 gender-matched healthy controls; patients were antidepressant-free for at least one week before morning blood draw.
- CD14+ monocytes were isolated from frozen peripheral blood mononuclear cells; quantitative PCR used a TaqMan Array panel of 47 inflammatory/immune genes plus GRα and GRβ; serum cytokines/chemokines were measured by cytometric bead array (IL1β, IL6, IL8, CCL2, VEGF, s-ICAM).
- Gene expression was analyzed by ANCOVA with age and gender, with Simes correction; Spearman correlations and linear/ordinal regression models examined relationships with HAMD and anxiety scores.
Limitations
- Stated: gene selection was based on prior whole-genome monocyte studies and limited to highly over- or underexpressed genes (>3.5-fold) involved in inflammation, so important causal genes may have been missed.
- Stated: the cytometric bead array was not sensitive enough to reliably detect IL-1β and IL6; below-sensitivity samples were replaced by the kit’s lowest sensitivity, and no spare serum was available for re-analysis.
- Evident from the text: controls were younger than MDD patients (HC=49 vs MDD=54, P<0.005), prior medication exposure differed, some subgroup comparisons were very small (e.g., MAOi n=2, atypical antipsychotics n=7), and the cross-sectional design cannot establish causality.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
0 Valid · 0 Not valid · 21 Not checked · 67 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Serum levels of IL6, IL8, CCL2 and VEGF were significantly increased in patients compared to controls.”
- Also stated in: § Inflammatory cytokines/chemokines · plain
“We found evidence for increased levels of IL6 (P=0.04), IL8 (P=0.004), CCL2 (P=0.04) and VEGF (P=0.028) in the serum of MDD patients (as compared to HC), but not of IL1β after Simes' multiple test correction (Figure 2).”
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Inflammatory cytokines/chemokines · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The outcomes of our study show that circulating monocytes overexpress inflammatory genes and underexpress the active GR variant (i.e. the α variant), suggesting a relative insensitivity of the monocytes for glucocorticoids.”
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The reduced GRα expression correlated strongly to the upregulation of the inflammatory genes in monocytes.”
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Abstract
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The downregulation of GRα negatively and significantly correlated with the overexpression of a large proportion of the monocyte activation genes of cluster 1 (26/30) and of cluster 2 (8/13).”
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Results > GRα and GRβ expression in monocytes and their relation with the expression of cluster 1 and cluster 2 inflammatory genes
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We have also conducted a multiple regression with all the molecules together to see whether it increased prediction. The only molecule that remained significantly associated was CDC42 (results are not shown).”
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Results > GRα, GRβ and inflammatory molecules in monocytes and their relation with clinical variables
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
42 more claims
Create a free account to see all 88 claims and to verify the 36 references still open.
- It may state two separate claims as one. 14
- Probably not a substantial claim. 33
Statistics recomputed
Every reported test result, recomputed from its test statistic and degrees of freedom. A result shows as not adding up only once an independent check has confirmed it.
- ConsistentF(1, 86) = 11.99reported p = .001 · recomputed p < .001
“F(1,86)=11.99, p = .001”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Results > GRα, GRβ and inflammatory molecules in monocytes and their relation with clinical variables
“GRα and EREG positively correlated to the severity of depression.”
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Discussion
“Particularly MDD patients with a high HAMD score had the lowest monocyte GRα expression.”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Discussion
“We found the raised levels of IL8 in the serum of MDD patients to correlate significantly and negatively to the GRα/β ratio of gene expression in the monocytes.”
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Results > Correlations between gene expression levels in circulating monocytes and serum levels of cytokines
“Interestingly, GRα expression negatively correlated to IL8 serum levels (S=−0.389, P=0.008); GRβ expression in monocytes correlated negatively to the CCL2 serum level (S=−0.309, P=0.035), and GRα/β positively correlated to CCL2 serum levels (S=0.292, P=0.046). No other correlation was found between GR splice variants and levels of cytokines in the serum.”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Results > Patients
“Only two MDD patients previously took MAOi (n=2) and presented higher levels of IL1β”
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Results > Patients
“(no MAOi=41.6±3.8, MAOi=18.0±5.8, P=0.001)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Results > Patients
“atypical antipsychotics 8.”
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Results > Patients
“MDD patients who previously took atypical antipsychotics (n=7)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Results > Patients
“At the time of blood sampling, all MDD patients were drug-free for at least one week.”
§ Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder > Materials and methods > Participants
“One patient continued with haloperidol.”
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · cited 1×
“With regard to IL8, the meta-analysis of Dowlati et al. (2009) concluded that evidence was lacking that IL8 levels were altered in MDD having evaluated four articles on IL8.”
Background(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Java Treeview—extensible visualization of microarray data
Saldanha, A. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth349 · Cited by 2,991
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
An improved Bonferroni procedure for multiple tests of significance
SIMES, R. J. (1986) · Biometrika · doi:10.1093/biomet/73.3.751 · Cited by 2,396
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Cited by
Palma-Gudiel, H., Córdova-Palomera, A., Leza, J. C., & Fañanás, L. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.016 · Cited by 347
Genetic Contributions of Inflammation to Depression
Barnes, J., Mondelli, V., & Pariante, C. M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.169 · Cited by 237
Leday, G. G. R., Vértes, P. E., Richardson, S., Greene, J. R., Regan, T., Khan, S., Henderson, R., Freeman, T. C., Pariante, C. M., Harrison, N. A., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.01.021 · Cited by 222
Self-citationArteaga-Henríquez, G., Simon, M. S., Burger, B., Weidinger, E., Wijkhuijs, A., Arolt, V., Birkenhager, T. K., Musil, R., Müller, N., & Drexhage, H. A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00458 · Cited by 215
Self-citationLow-grade inflammation predicts persistence of depressive symptoms
Zalli, A., Jovanova, O., Hoogendijk, W. J. G., Tiemeier, H., & Carvalho, L. A. (2016) · Psychopharmacology · doi:10.1007/s00213-015-3919-9 · Cited by 193
Self-citationA meta-analysis of chemokines in major depression
Eyre, H. A., Air, T., Pradhan, A., Johnston, J., Lavretsky, H., Stuart, M. J., & Baune, B. T. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.006 · Cited by 188
Wang, L., Wang, R., Liu, L., Qiao, D., Baldwin, D. S., & Hou, R. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.02.021 · Cited by 185
Deficiencies of the T and natural killer cell system in major depressive disorder
Grosse, L., Hoogenboezem, T., Ambrée, O., Bellingrath, S., Jörgens, S., de Wit, H. J., Wijkhuijs, A. M., Arolt, V., & Drexhage, H. A. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.12.003 · Cited by 163
Self-citationNowak, W., Grendas, L. N., Sanmarco, L. M., Estecho, I. G., Arena, Á. R., Eberhardt, N., Rodante, D. E., Aoki, M. P., Daray, F. M., Carrera Silva, E. A., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.063 · Cited by 159
Role of neuro-immunological factors in the pathophysiology of mood disorders
Bhattacharya, A., Derecki, N. C., Lovenberg, T. W., & Drevets, W. C. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4214-0 · Cited by 149
Sharma, A. N., da Costa e Silva, B. F. B., Soares, J. C., Carvalho, A. F., & Quevedo, J. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.067 · Cited by 142
“Sixteen studies exclusively evaluated MDD patients (Berent et al., 2014; L. A. Carvalho et al., 2014; L. A. Carvalho et al., 2013; Clark-Raymond et al., 2014; Dome et al., 2012; Dome et al., 2009; Elfving et al., 2014; Fornaro et al., 2013; Galecki, Galecka, et al., 2013; Galecki, Orzechowska, et…”
InfluentialAnti-inflammatory treatments for mood disorders: Systematic review and meta-analysis
Husain, M. I., Strawbridge, R., Stokes, P. R., & Young, A. H. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725711 · Cited by 139
Stress-induced blood brain barrier disruption: Molecular mechanisms and signaling pathways
Welcome, M. O., & Mastorakis, N. E. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104769 · Cited by 139
The neuroimmunology of social-stress-induced sensitization
Biltz, R. G., Sawicki, C. M., Sheridan, J. F., & Godbout, J. P. (2022) · Nature Immunology · doi:10.1038/s41590-022-01321-z · Cited by 132
Liu, J., Buisman-Pijlman, F., & Hutchinson, M. R. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00309 · Cited by 119
Central nervous system myeloid cells as drug targets: current status and translational challenges
Biber, K. P. H., Möller, T., Boddeke, E., & Prinz, M. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.14 · Cited by 116
Grosse, L., Carvalho, L. A., Birkenhäger, T. K., Hoogendijk, W. J. G., Kushner, S. A., Drexhage, H. A., & Bergink, V. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3943-9 · Cited by 115
Self-citationPerrin, A. J., Horowitz, M. A., Roelofs, J., Zunszain, P. A., & Pariante, C. M. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00423 · Cited by 112
Monocyte mitochondrial dysfunction, inflammaging, and inflammatory pyroptosis in major depression
Simon, M. S., Schiweck, C., Arteaga-Henríquez, G., Poletti, S., Haarman, B. C. M., Dik, W. A., Schwarz, M., Vrieze, E., Mikova, O., Joergens, S., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110391 · Cited by 109
Self-citationGialluisi, A., Bonaccio, M., Castelnuovo, A. F. D., Costanzo, S., Curtis, A. D., Sarchiapone, M., Cerletti, C., Donati, M. B., de Gaetano, G., Iacoviello, L., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.04.041 · Cited by 104
Lisboa, S. F. D. S., Niraula, A., Resstel, L. B. M., Guimarães, F. S., Godbout, J. P., & Sheridan, J. F. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0064-2 · Cited by 98
Welcome, M. O. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00712-8 · Cited by 96
Böttcher, C., Fernández‐Zapata, C., Snijders, G. J. L., Schlickeiser, S., Sneeboer, M. A. M., Kunkel, D., de Witte, L. D., & Priller, J. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00992-2 · Cited by 93
Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis
Carvalho, A. F., Köhler, C. A., McIntyre, R. S., Knöchel, C., Brunoni, A. R., Thase, M. E., Quevedo, J., Fernandes, B. S., & Berk, M. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.002 · Cited by 92
Manuel, R., Gorissen, M., Zethof, J., Ebbesson, L. O. E., van de Vis, H., Flik, G., & van den Bos, R. (2014) · Journal of Experimental Biology · doi:10.1242/jeb.109736 · Cited by 91
Vortioxetine exerts anti‐inflammatory and immunomodulatory effects on human monocytes/macrophages
Talmon, M., Rossi, S., Pastore, A., Cattaneo, C. I., Brunelleschi, S., & Fresu, L. G. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14074 · Cited by 83
Hird, E. J., Slanina-Davies, A., Lewis, G., Hamer, M., & Roiser, J. P. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02922-y · Cited by 79
The impact of stress on immune systems and its relevance to mental illness
Ishikawa, Y., & Furuyashiki, T. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.09.005 · Cited by 78
S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression
Ambrée, O., Bergink, V., Grosse, L., Alferink, J., Drexhage, H. A., Rothermundt, M., Arolt, V., & Birkenhäger, T. K. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv103 · Cited by 78
Self-citationMorris, G., Reiche, E. M. V., Murru, A., Carvalho, A. F., Maes, M. H. J., Berk, M., & Puri, B. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0843-5 · Cited by 78
Bhattacharya, A., & Drevets, W. C. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_43 · Cited by 77
Repeated exposure to systemic inflammation and risk of new depressive symptoms among older adults
Bell, J. A., Kivimäki, M., Bullmore, E. T., Steptoe, A., Bullmore, E. T., Vértes, P. E., Cardinal, R. N., Richardson, S. T., Leday, G. G. R., Freeman, T. C., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.155 · Cited by 73
Self-citationGrosse, L., Carvalho, L. A., Wijkhuijs, A. J. M., Bellingrath, S., Ruland, T., Ambrée, O., Alferink, J., Ehring, T., Drexhage, H. A., & Arolt, V. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.08.004 · Cited by 71
Self-citationBrain-immune crosstalk in the treatment of major depressive disorder
Branchi, I., Poggini, S., Capuron, L., Benedetti, F., Poletti, S., Tamouza, R., Drexhage, H. A., Penninx, B. W. J. H., & Pariante, C. M. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.016 · Cited by 71
Self-citationTseng, P., Cheng, Y., Chen, Y., Wu, C.-K., & Lin, P. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.001 · Cited by 66
Becking, K., Haarman, B. C. M., Grosse, L., Nolen, W. A., Claes, S. J., Arolt, V., Schoevers, R. A., & Drexhage, H. A. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.004 · Cited by 65
Self-citationTargeting the Adaptive Immune System in Depression: Focus on T Helper 17 Cells
Beurel, E., Medina-Rodriguez, E. M., & Jope, R. S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000256 · Cited by 64
Berentschot, J. C., Drexhage, H. A., Mersha, D. G. A., Wijkhuijs, A. J. M., GeurtsvanKessel, C. H., Koopmans, M., Voermans, J. J. C., Hendriks, R. W., Nagtzaam, N. M. A., de Bie, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1254899 · Cited by 62
Self-citationSchiweck, C., Claes, S., Van Oudenhove, L., Lafit, G., Vaessen, T., de Beeck, G. O., Berghmans, R., Wijkhuijs, A., Müller, N., Arolt, V., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00979-z · Cited by 59
Self-citationHasselmann, H., Gamradt, S., Taenzer, A., Nowacki, J., Zain, R., Patas, K., Ramien, C., Paul, F., Wingenfeld, K., Piber, D., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02693 · Cited by 56
Depressive symptoms and immune transcriptional profiles in late adolescents
Chiang, J. J., Cole, S. W., Bower, J. E., Irwin, M. R., Taylor, S. E., Arevalo, J. M. G., & Fuligni, A. J. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.03.004 · Cited by 55
Transcriptomic predictors of inflammation-induced depressed mood
Cho, J. H.-J., Irwin, M. R., Eisenberger, N. I., Lamkin, D. M., & Cole, S. W. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0316-9 · Cited by 54
Neuroinflammatory genes associated with post-traumatic stress disorder: implications for comorbidity
Zass, L. J., Hart, S. A., Seedat, S., Hemmings, S. M. J., & Malan‐Müller, S. (2016) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000143 · Cited by 54
Asslih, S., Damri, O., & Agam, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116138 · Cited by 54
Chen, X., Feng, L., Cai, B., Chen, X., & Chen, G. (2017) · The Journal of Comparative Neurology · doi:10.1002/cne.24311 · Cited by 52
Low glucocorticoids in stress-related disorders: the role of inflammation
Sarapultsev, A., Sarapultsev, P., Dremencov, E., Komelkova, M. V., Tseilikman, O. B., & Цейликман, В. Э. (2020) · Stress · doi:10.1080/10253890.2020.1766020 · Cited by 50
Targeting the CCL2-CCR2 Axis in Depressive Disorders
Curzytek, K., & Leśkiewicz, M. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00280-w · Cited by 47
Zhang, L., Zhang, X., Zheng, J., Liu, Y., Wang, J., Wang, G., Zhang, H. P., Kang, D. Y., Peng, Z. G., Ji, Y. L., et al. (2019) · Clinical & Experimental Allergy · doi:10.1111/cea.13346 · Cited by 47
Identification of IL6 as a susceptibility gene for major depressive disorder
Zhang, C., Wu, Z., Zhao, G., Wang, F., & Fang, Y. (2016) · Scientific Reports · doi:10.1038/srep31264 · Cited by 46
The relationship between chronic immune response and neurodegenerative damage in long COVID-19
Elizalde-Díaz, J. P., Miranda-Narváez, C. L., Martínez‐Lazcano, J. C., & Martínez‐Martínez, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1039427 · Cited by 46
Krause, D., Myint, A.-M., Schuett, C., Musil, R., Dehning, S., Cerovecki, A., Riedel, M. J., Arolt, V., Schwarz, M., & Müller, N. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00016 · Cited by 46
Beydoun, M. A., Beydoun, H. A., Dore, G. A., Canas, J. A., Kuczmarski, M. F., Evans, M. K., & Zonderman, A. B. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.180 · Cited by 45
Woo, H. I., Lim, S.-W., Myung, W., Kim, D. K., & Lee, S.-Y. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0123-0 · Cited by 42
Overlapping evidence of innate immune dysfunction in psychotic and affective disorders
Hughes, H. K., & Ashwood, P. (2020) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2020.100038 · Cited by 39
Moschny, N., Zindler, T., Jahn, K., Dorda, M., Davenport, C., Wiehlmann, L., Maier, H. B., Eberle, F. C., Bleich, S., Neyazi, A., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00891-9 · Cited by 39
Th17 Cells, Glucocorticoid Resistance, and Depression
Khantakova, J. N., Mutovina, A., Ayriyants, K. A., & Bondar, N. P. (2023) · Cells · doi:10.3390/cells12232749 · Cited by 38
Welcome, M. O., & Mastorakis, N. E. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105557 · Cited by 38
IL-8 (CXCL8) Correlations with Psychoneuroimmunological Processes and Neuropsychiatric Conditions
Shkundin, A., & Halaris, A. E. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14050488 · Cited by 36
SCI and depression: Does inflammation commandeer the brain?
Brakel, K., & Hook, M. A. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.112977 · Cited by 36
Janssen, E. P. C. J., Köhler, S., Geraets, A. F. J., Stehouwer, C. D. A., Schaper, N. C., Sep, S. J. S., Henry, R. M. A., Kallen, C., Schalkwijk, C. G., Koster, A., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.06.013 · Cited by 35
The impact of genetic factors on response to glucocorticoids therapy in IBD
Gabryel, M., Skrzypczak-Zielińska, M., Kucharski, M., Słomski, R., & Dobrowolska, A. (2016) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1132336 · Cited by 34
Cheng, T., Dimitrov, S., Pruitt, C., & Hong, S. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.01.008 · Cited by 33
Belzeaux-R, R., Lin, C., Ding, Y., Bergon, A., Ibrahim, E. C., Turecki, G., Tseng, G. C., & Sibille, E. L. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.009 · Cited by 32
Pu, J., Liu, Y., Gui, S., Tian, L., Xu, S., Song, X., Zhong, X., Chen, Y., Chen, X., Yu, Y., et al. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113319 · Cited by 32
Chen, X., Feng, L., Cai, B., Chen, X., Qin, L., & Chen, G. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0102-1 · Cited by 30
Chiang, T.-I., Hung, Y.-Y., Wu, M., Huang, Y., & Kang, H. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.04.021 · Cited by 30
Moisan, M., Foury, A., Dexpert, S., Cole, S. W., Beau, C., Forestier, D., Ledaguenel, P., Magne, E., & Capuron, L. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01323-9 · Cited by 29
Vogels, R. J., Koenders, M. A., van Rossum, E. F. C., Spijker, A. T., & Drexhage, H. A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00034 · Cited by 29
Self-citationArteaga-Henríquez, G., Burger, B., Weidinger, E., Grosse, L., Moll, N., Schütze, G. A., Schwarz, M., Wijkhuijs, A. J. M., de Beeck, G. O., Berghmans, R., et al. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110226 · Cited by 26
Self-citationNikkheslat, N., Pariante, C. M., & Zunszain, P. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00003-9 · Cited by 26
An interoceptive model of energy allostasis linking metabolic and mental health
Mehrhof, S. Z., Fleming, H. A., & Nord, C. L. (2025) · Science Advances · doi:10.1126/sciadv.ady4356 · Cited by 24
Hughes, H. K., Yang, H. T., Lesh, T. A., Carter, C. S., & Ashwood, P. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02648-y · Cited by 24
McWhirt, J., Sathyanesan, M., Sampath, D., & Newton, S. S. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100169 · Cited by 23
Drexhage, H. A., Bergink, V., Poletti, S., Benedetti, F., & Osborne, L. M. (2024) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2024.2420053 · Cited by 20
Self-citationMoschny, N., Jahn, K., Maier, H. B., Khan, A. Q., Ballmaier, M., Liepach, K., Sack, M., Skripuletz, T., Bleich, S., Frieling, H., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.03.019 · Cited by 20
Maier, H. B., Moschny, N., Eberle, F. C., Jahn, K., Folsche, T., Schülke, R., Bleich, S., Frieling, H., & Neyazi, A. (2023) · Pharmacopsychiatry · doi:10.1055/a-2034-6536 · Cited by 19
Santiago, R. A., Bavaresco, S. P. P., Citrangulo, S. M. T. G., Medronho, R. D. A., Sampaio, V., & Costa, A. J. L. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012810 · Cited by 19
Lorenz, D. R., Misra, V., & Gabuzda, D. H. (2019) · Human Genomics · doi:10.1186/s40246-019-0247-x · Cited by 18
Liu, X., Jin, G., Fan, B., Yang, X., Wang, L., Wang, M., Yuan, Y., & Zhu, Q. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.03.048 · Cited by 17
Altered Levels of Salivary Cytokines in Patients with Major Depressive Disorder
Yui, S., Sasayama, D., Yamaguchi, M., & Washizuka, S. (2022) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2022.107390 · Cited by 16
Park, B., & Choi, G. E. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102786 · Cited by 16
Zhang, Z., & Chen, G. (2020) · The Journal of Comparative Neurology · doi:10.1002/cne.24921 · Cited by 16
Nicoloro‐SantaBarbara, J. M., Carroll, J., Minissian, M., Kilpatrick, S. J., Cole, S. W., Merz, C. N. B., & Accortt, E. E. (2022) · American Journal of Reproductive Immunology · doi:10.1111/aji.13619 · Cited by 16
The impact of poor diet and early life stress on memory status
Morris, M. J., Le, V., & Maniam, J. (2016) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.04.002 · Cited by 16
Inflammation as a mediator of stress-related psychiatric disorders
Flux, M. C., & Lowry, C. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00052-6 · Cited by 15
SUMO E3 ligase PIAS1 is a potential biomarker indicating stress susceptibility
Lin, H., Liu, Y.-S., Huang, C., Cathomas, F., Liu, K., Wang, J., Cheng, H., Lai, S., Liu, Y., Chen, C., et al. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104800 · Cited by 14
Differential Macrophage Responses in Affective Versus Non-Affective First-Episode Psychosis Patients
Hughes, H. K., Mills-Ko, E., Yang, H. T., Lesh, T. A., Carter, C. S., & Ashwood, P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.583351 · Cited by 14
Noortgate, M. V. D., Eede, F. V. D., Coppens, V., Giltay, E. J., Picker, L. D., & Morrens, M. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.100965 · Cited by 12
Adiponectin predicts poor response to antidepressant drugs in major depressive disorder
Benedetti, F., Branchi, I., Poletti, S., Lorenzi, C., Bigai, G., Colombo, C., & Zanardi, R. (2021) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2793 · Cited by 12
Taylor, R., Schlosser, R. J., Soler, Z. M., Mattos, J. L., & Mulligan, J. K. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22120 · Cited by 10
Alvarenga, M. E., & Byrne, D. G. (2016) · Springer eBooks · doi:10.1007/978-981-287-206-7 · Cited by 10
Genç, A., Dalkıran, M., Aydın, E. P., Uyar, E. T., Alkan, A. A., Güven, D., Özer, Ö. A., & Karamustafalıoğlu, O. (2018) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2018.1480785 · Cited by 9
Berentschot, J. C., Drexhage, H. A., Mersha, D. G. A., Wijkhuijs, A. J. M., GeurtsvanKessel, C. H., Koopmans, M., Voermans, J. J. C., Heijenbrok‐Kal, M. H., Bek, L. M., Ribbers, G. M., et al. (2022) · medRxiv · doi:10.1101/2022.09.15.22279970 · Cited by 9
Self-citationMileva, G. R., Moyes, C., Syed, S., & Bielajew, C. H. (2017) · Neuropsychobiology · doi:10.1159/000476035 · Cited by 7
Jönsson, S., Lundberg, A. K., Chung, R. W. S., & Jonasson, L. (2018) · Annals of Medicine · doi:10.1080/07853890.2018.1445278 · Cited by 7
McGuinness, B. W., & Harkin, A. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_3 · Cited by 7
Luo, Y., Wang, S., Cheng, Q., Li, J., Zhang, H., Wang, J., Luo, J., Chen, P., Zhang, Q., Xie, J., et al. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100893 · Cited by 6
Gulbaz, Z.-U.-A., Mirza, S., Naveed, S., Azeem, M. W., Husain, N., & Cheema, M. I. (2025) · Psychiatric Quarterly · doi:10.1007/s11126-025-10223-w · Cited by 6
Gene Expression of Inflammation Markers in Depression
Ciobanu, L. G., & Baune, B. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00011-8 · Cited by 6
Neonatal Immune Activation May Provoke Long-term Depressive Attributes
Marzzani, S. H. S., Dias, P., Freiberger, V., Ventura, L., Silva, B. B., Dutra, M. L., Bobinski, F., Schlindwein, A. D., Cassol-Jr, O. J., & Comim, C. M. (2019) · Current Neurovascular Research · doi:10.2174/1567202616666191007125502 · Cited by 6
Metadata
- Authors
- Carvalho, L. A., Bergink, V, Sumaski, L., Wijkhuijs, J., Hoogendijk, W. J., Birkenhager, T. K., & Drexhage, H. A.
- Affiliations
- University College London (GB)
- Erasmus MC (NL)
- University Hospital Münster (DE)
- Corresponding author
- Carvalho, L A
- Venue
- Translational Psychiatry
- Published
- 2014-01-14
- Volume
- 4
- Issue
- 1
- Pages
- e344-e344
- ISSN
- 2158-3188 (ISSN-L)
- PMC
- PMC3905228
- OpenAlex
- W2013799046
- Cited by
- 139
- References
- 55
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 8 · 2023: 6 · 2022: 13 · 2021: 11 · 2020: 16 · 2019: 15 · 2018: 16 · 2017: 11 · 2016: 16 · 2015: 12 · 2014: 4
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (unspecified)
- Locations
- Translational Psychiatry (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- British Heart Foundation (RG/10/005/28296)
- King's College London
- European College of Neuropsychopharmacology
- Menzies Centre for Australian Studies, King's College London, University of London
- Biomedical Research Council
- FP7 Health (222963)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- major depressive disorder, endogenous depression, monocytes, glucocorticoid receptor alpha, glucocorticoid receptor beta, glucocorticoid resistance, inflammation, immune activation, gene expression, interleukin-6, interleukin-8, MCP-1, vascular endothelial growth factor, cytokines, chemokines
- MeSH terms
- Adult, Aged, Aged, 80 and over, Major Depressive Disorder, Female, Gene Expression Regulation, Humans, Inflammation, Male, Middle Aged, Monocytes, Receptors, Glucocorticoid, Gene Expression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.